DHA Softgel Capsule Ingredients & Drug Interactions
by Exeltis USA
What is this page for?
First and foremost: checking DHA Softgel Capsule against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
DHA Softgel Capsule is a dietary supplement by Exeltis USA with 1 active ingredient. Its ingredients are commonly taken for vegan/vegetarian source of omega-3s (dha and epa), heart and triglyceride health, brain and eye support.Based on those ingredients, 375 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Algal Oil Blend. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against DHA Softgel Capsule by Exeltis USA
Ask about any prescription or over-the-counter medication and we check it for interactions with DHA Softgel Capsule by Exeltis USA — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of DHA Softgel Capsule by Exeltis USA
Four independent checks of what is known — a summary of the available information, not a grade of the product itself.
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
None of the active ingredients could be matched to our evidence database, so intended use can't be graded.
Why this rating?
- None of the active ingredients could be matched to a HelloPharmacist monograph, so intended use can't be graded against our evidence data.
Every active ingredient lists its own amount on the label.
Why this rating?
- The label discloses an exact amount for 1 of its 1 active ingredient.
- “Algal Oil Blend” is a proprietary blend — the label gives one combined amount (486 mg) without saying how much of each component you get.
None of the active ingredients could be matched to our interaction database.
Why this rating?
- We couldn't match any ingredient to a HelloPharmacist monograph, so there was nothing to check interactions against.
None of the active ingredients could be matched to our safety data.
Why this rating?
- We couldn't match any ingredient to a HelloPharmacist monograph, so there was no safety data to measure.
HelloPharmacist summaryFully disclosed formula with no assessable stated purpose. Medication interactions could not be assessed, and safety information could not be assessed.
Assessment coverage: 0 of 1 active ingredient matched to our full ingredient reviews (monographs). Based on the product label dated Dec 26, 2020.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about DHA Softgel Capsule, straight from the product label.
| Brand | Exeltis USA |
|---|---|
| Net contents | 0 Not Present |
| Market status | Off market |
| Date entered into DSLD | Dec 26, 2020 |
| DSLD ID | 239666 |
| Product type | Fat/fatty Acid |
| Supplement form | Capsule |
| Dietary claims / uses | Nutrient, All Other |
| Intended target group(s) | Pregnant Women, Adult Female (18 - 50 Years), Lactating |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for DHA Softgel Capsule by Exeltis USA, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| Docosahexaenoic Acid | 250 mg | -- |
| Algal Oil Blend | 486 mg | -- |
Other ingredients: Gelatin, Glycerin, Water
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements
0642-0076-30
Composition:
How supplied: Vitafol-OB+DHA is available as a light blue caplet debossed EV0079 and one amber-colored DHA softgel capsule. Available in Box of Unit-Dose pack of 30 (6 child resistant blister cards of 5 caplets and 5 softgel capsules each), (0642-0076-30) and as professional samples (0642-0076-03).
Rev. November 2018
FDA Statement of Identity
Prenatal Supplement with DHA Rx
Formula
Indications and usage: Vitafol-OB+DHA is indicated to provide vitamin, mineral and omega-3 fatty acid supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother, including individuals with known allergies to fish.
Vitafol-OB+DHA
Formulation
Vitafol-OB+DHA does not contain fish, fish oils, fish proteins or fish byproducts.
Precautions
Contraindications: Vitafol-OB+DHA is contraindicated in patients with hypersensitivity to any of its components or color additives.
Warnings/Precautions: Consumption of more than 3 grams of omega-3 fatty acids per day from all sources may lead to excessive bleeding. Supplemental intake of omega-3 fatty acids, such as DHA exceeding 2 grams per day is not recommended. Avoid overdosage.
Keep out of the reach of children.
Drug interactions: Consult appropriate references for additional specific vitamin-drug interactions.
Pediatric use: Not for pediatric use.
Adverse reactions: Adverse reactions have been reported with specific vitamins and minerals, but generally at doses substantially higher than those in Vitafol-OB+DHA.
Allergic reactions have been reported with some forms of gum acacia to include respiratory problems and skin lesions.
Suggested/Recommended/Usage/Directions
Dosage and administration: Before, during and after pregnancy, one caplet and one soft-gel capsule daily, or as directed by a physician.
Storage
Store at room temperature, approximately 15 degrees - 30 degrees C (59 degrees - 86 degrees F), avoid excessive heat and moisture.
Brand IP Statement(s)
2018 Exeltis USA, Inc. U.S. Patent No. 6,814,983; 7,390,509 Vitafol is a trademark of Exeltis USA, Inc.
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
DHA Softgel Capsule by Exeltis USA label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in DHA Softgel Capsule by Exeltis USA
This is the 1 active ingredient this product is made of. Select it to open its full monograph.
Serving size1 Not Present Dosage formCapsule Amounts shown are per serving.
Algal Oil Blend
Interacts with375 drugs
Algal oil is a plant-based source of the omega-3 fats DHA and (in some products) EPA, making it a popular alternative to fish oil for vegetarians, veg...
Algal Oil Blend monograph & interactions- › Docosahexaenoic Acid
Other (inactive) ingredients: Gelatin, Glycerin, Water. These complete the product’s ingredient list but are not active constituents.
DHA Softgel Capsule by Exeltis USA Drug Interactions
DHA Softgel Capsule contains a single active ingredient, and it has known interactions with 375 medications. Here’s the picture, then you can look up your own drug.
Want to check YOUR meds against DHA Softgel Capsule?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in DHA Softgel Capsule interact with 375 drugs. Click any drug to see the details.
1 of the 1 ingredient in DHA Softgel Capsule interact with drugs. Each result below shows which ingredient is responsible. Algal Oil Blend
AcarboseGlucobay, Prandase, Precose
How Acarbose interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antidiabetes drugs might interfere with the effects of antidiabetes drugs and reduce their effects.
Read the full Algal Oil Blend + Acarbose interactionAcebutololRhotral, Sectral
How Acebutolol interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Acebutolol interactionAcetazolamideAk-Zol, Diamox
How Acetazolamide interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Acetazolamide interactionAcetohexamideDymelor
How Acetohexamide interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antidiabetes drugs might interfere with the effects of antidiabetes drugs and reduce their effects.
Read the full Algal Oil Blend + Acetohexamide interactionAlbiglutideTanzeum
How Albiglutide interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antidiabetes drugs might interfere with the effects of antidiabetes drugs and reduce their effects.
Read the full Algal Oil Blend + Albiglutide interactionAliskirenTekturna
How Aliskiren interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Aliskiren interactionAlogliptinNesina
How Alogliptin interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antidiabetes drugs might interfere with the effects of antidiabetes drugs and reduce their effects.
Read the full Algal Oil Blend + Alogliptin interactionAlogliptin, MetforminKazano
How Alogliptin, Metformin interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antidiabetes drugs might interfere with the effects of antidiabetes drugs and reduce their effects.
Read the full Algal Oil Blend + Alogliptin, Metformin interactionAlogliptin, PioglitazoneOseni
How Alogliptin, Pioglitazone interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antidiabetes drugs might interfere with the effects of antidiabetes drugs and reduce their effects.
Read the full Algal Oil Blend + Alogliptin, Pioglitazone interactionAmbrisentanLetairis, Volibris
How Ambrisentan interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Ambrisentan interactionAmilorideAmilamont, Midamor
How Amiloride interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Amiloride interactionAmiloride, HydrochlorothiazideAmil-Co, Amilzide, Moduret 25, Moduretic
How Amiloride, Hydrochlorothiazide interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Amiloride, Hydrochlorothiazide interactionAmlodipineNorliqva
How Amlodipine interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Amlodipine interactionAmlodipine BenzoateKaterzia
How Amlodipine Benzoate interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Amlodipine Benzoate interactionAmlodipine BesilateIstin
How Amlodipine Besilate interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Amlodipine Besilate interactionAmlodipine BesylateNorvasc
How Amlodipine Besylate interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Amlodipine Besylate interactionAmlodipine Besylate, BenazeprilLotrel
How Amlodipine Besylate, Benazepril interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Amlodipine Besylate, Benazepril interactionAmlodipine, CelecoxibConsensi
How Amlodipine, Celecoxib interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Amlodipine, Celecoxib interactionAmmonium ChlorideAmmonium Chloride
How Ammonium Chloride interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Ammonium Chloride interactionAntidiabetes, Dipeptidyl Peptidase-4 (dpp-iv) InhibitorGlyxambi
How Antidiabetes, Dipeptidyl Peptidase-4 (dpp-iv) Inhibitor interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antidiabetes drugs might interfere with the effects of antidiabetes drugs and reduce their effects.
Read the full Algal Oil Blend + Antidiabetes, Dipeptidyl Peptidase-4 (dpp-iv) Inhibitor interactionAprocitentanTryvio
How Aprocitentan interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Aprocitentan interactionAtenololAtenix, Tenormin
How Atenolol interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Atenolol interactionAtenolol, ChlortalidoneAtenixCo, Tenoret 50, Totaretic
How Atenolol, Chlortalidone interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Atenolol, Chlortalidone interactionAtenolol, ChlorthalidoneTenoretic
How Atenolol, Chlorthalidone interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Atenolol, Chlorthalidone interactionAzilsartanEdarbi
How Azilsartan interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Azilsartan interactionAzilsartan, ChlorthalidoneEdarbyclor
How Azilsartan, Chlorthalidone interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Azilsartan, Chlorthalidone interactionBenazeprilLotensin
How Benazepril interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Benazepril interactionBenazepril, HydrochlorothiazideLotensin HCT
How Benazepril, Hydrochlorothiazide interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Benazepril, Hydrochlorothiazide interactionBendroflumethiazideAprinox, Naturetin, Neo-NaClex
How Bendroflumethiazide interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Bendroflumethiazide interactionBendroflumethiazide, NadololCorzide
How Bendroflumethiazide, Nadolol interacts with DHA Softgel Capsule — through 1 ingredient. Tap an ingredient for the detail:
Algal Oil BlendAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Read the full Algal Oil Blend + Bendroflumethiazide, Nadolol interactionEach ingredient & the kinds of drugs it affects
For each ingredient in DHA Softgel Capsule with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.
Algal Oil Blend
Antidiabetes Drugs
Theoretically, taking algal oil with antidiabetes drugs might interfere with the effects of antidiabetes drugs and reduce their effects.
Most algal oil contains docosahexaenoic acid (DHA). Clinical research in people with type 2 diabetes, including those taking antidiabetes drugs, shows that taking DHA 4 grams daily for 6 weeks increases fasting blood glucose levels by about 18 mg/dL when compared with taking olive oil.
Antihypertensive Drugs
Theoretically, taking algal oil with antihypertensive drugs might increase the risk of hypotension.
Algal oil usually contains docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA). There is evidence that fish oil, which also contains DHA and EPA, can modestly lower blood pressure and might have additive effects in patients treated with antihypertensive drugs.
Anticoagulant/Antiplatelet Drugs
Theoretically, algal oil may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
The risk of interaction is highest for algal oil containing high amounts (> 2 grams daily) of eicosapentaenoic acid (EPA), or EPA and docosahexaenoic acid (DHA). High doses of EPA or oils containing EPA and DHA can reduce platelet aggregation in humans. However, most algal oil contains very little EPA and larger amounts of DHA. While some conflicting evidence exist, most research shows that DHA alone does not affect blood clotting.
Brand information
Manufacturer and brand details for DHA Softgel Capsule, from the product label.
Exeltis USA
See all Exeltis USA products- Name
- Exeltis USA, Inc.
- City
- Florham Park
- State
- NJ
- ZipCode
- 07932
- Phone Number
- 1-877-324-9349
- Web Address
- www.exeltisusa.com
DHA Softgel Capsule by Exeltis USA: Common Questions
Does DHA Softgel Capsule by Exeltis USA interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if DHA Softgel Capsule is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind DHA Softgel Capsule’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Sources & How We Checked
DHA Softgel Capsule's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 43 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Algal Oil 43 references
- Prisco D, Paniccia R, Bandinelli B, et al. Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients. Thromb Res 1998;1:105-12.
- Grimsgaard S, Bonaa KH, Hansen JB, Nordoy A. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr 1997;66:649-59.
- Toft I, Bonaa KH, Ingebretsen OC, et al. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. Ann Intern Med 1995;123:911-8.
- Sacks FM, Hebert P, Appel LJ, et al. Short report: the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the trials of hypertension prevention. J Hypertens 1994;12:209-13.
- Vandongen R, Mori TA, Burke V, et al. Effects on blood pressure of omega 3 fats in subjects at increased risk of cardiovascular disease. Hypertension 1993;22:371-9. PubMed
- FDA. Center for Food Safety and Applied Nutrition. Letter regarding dietary supplement health claim for omega-3 fatty acids and coronary heart disease. Available at: http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-Rpt0272-38-Appendix-D-Reference
- Leaf A. On the reanalysis of the GISSI-Prevenzione. Circulation 2002;105:1874-5. PubMed
- Connor WE. n-3 Fatty acids from fish and fish oil: panacea or nostrum? Am J Clin Nutr 2001;74;415-6. PubMed
- Calder PC. N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale? Nutr Res 2001;21:309-41. DOI
- Pedersen HS, Mulvad G, Seidelin KN, et al. N-3 fatty acids as a risk factor for haemorrhagic stroke. Lancet 1999;353:812-3. PubMed
- Terano T, Hirai A, Hamazaki T, et al. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis 1983;46:321-31.. PubMed
- Kris-Ehterton PM, Harris WS, Appel LJ, et al. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-57. PubMed
- Woodman RJ, Mori TA, Burke V, et al. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002;76:1007-15.. PubMed
- Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003;160:996-8.. PubMed
- Leng GC, Smith FB, Fowkes FG, et al. Relationship between plasma essential fatty acids and smoking, serum lipids, blood pressure and haemostatic and rheological factors. Prostaglandins Leukot Essent Fatty Acids 1994;51:101-8. PubMed
- Nelson GJ, Schmidt PS, Bartolini GL, et al. The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 1997;32:1129-36. PubMed
- Wheaton DH, Hoffman DR, Locke KG, et al. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa. Arch Ophthalmol 2003;121:1269-78. PubMed
- Svaneborg N, Kristensen SD, Hansen LM, et al. The acute and short-time effect of supplementation with the combination of n-3 fatty acids and acetylsalicylic acid on platelet function and plasma lipids. Thromb Res 2002;105:311-6. PubMed
- Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369:1090-8. PubMed
- von Houwelingen R, Nordøy A, van der Beek E, et al. Effect of a moderate fish intake on blood pressure, bleeding time, hematology, and clinical chemistry in healthy males. Am J Clin Nutr. 1987 Sep;46(3):424-36. PubMed
- Goodnight SH Jr, Harris WS, Connor WE. The effects of dietary omega 3 fatty acids on platelet composition and function in man: a prospective, controlled study. Blood. 1981 Nov;58(5):880-5. DOI
- Mori, T. A., Bao, D. Q., Burke, V., Puddey, I. B., and Beilin, L. J. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 1999;34(2):253-260. PubMed
- Nestel, P., Shige, H., Pomeroy, S., Cehun, M., Abbey, M., and Raederstorff, D. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am.J.Clin.Nutr. 2002;76(2):326-330. PubMed
- Woodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Barden, A., Watts, G. F., and Beilin, L. J. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients PubMed
- Theobald, H. E., Goodall, A. H., Sattar, N., Talbot, D. C., Chowienczyk, P. J., and Sanders, T. A. Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. J Nutr 2007;137(4):973-978.
- Mischoulon D, Best-Popescu C, Laposata M, et al. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol. 2008;18(9):639-645. PubMed
- Arterburn, L. M., Oken, H. A., Bailey, Hall E., Hamersley, J., Kuratko, C. N., and Hoffman, J. P. Algal-oil capsules and cooked salmon: nutritionally equivalent sources of docosahexaenoic acid. J Am Diet Assoc 2008;108(7):1204-1209. PubMed
- Zucker, M. L., Bilyeu, D. S., Helmkamp, G. M., Harris, W. S., and Dujovne, C. A. Effects of dietary fish oil on platelet function and plasma lipids in hyperlipoproteinemic and normal subjects. Atherosclerosis 1988;73(1):13-22. PubMed
- Bernstein AM, Ding EL, Willett WC, Rimm EB. A meta-analysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease. J Nutr. 2012;142(1):99-104.
- Carlson SE, Colombo J, Gajewski BJ, Gustafson KM, Mundy D, Yeast J, Georgieff MK, Markley LA, Kerling EH, Shaddy DJ. DHA supplementation and pregnancy outcomes. Am J Clin Nutr. 2013 Apr;97(4):808-15. PubMed
- Fu YQ, Zheng JS, Yang B, Li D. Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. J Epidemiol. 2015;25(4):261-74. PubMed
- Imhoff-Kunsch B, Stein AD, Villalpando S, Martorell R, Ramakrishnan U. Docosahexaenoic acid supplementation from mid-pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. J Nutr. 2011 Feb;141(2): PubMed
- Mulder KA, King DJ, Innis SM. Omega-3 fatty acid deficiency in infants before birth identified using a randomized trial of maternal DHA supplementation in pregnancy. PLoS One. 2014 Jan 10;9(1):e83764. PubMed
- Richardson AJ, Burton JR, Sewell RP, Spreckelsen TF, Montgomery P. Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: a randomized, controlled trial (the DOLAB Study). PLoS One. 2012;7(9):e43909. PubMed
- Ballantyne CM, Bays HE, Kastelein JJ, Stein E, Isaacsohn JL, Braeckman RA, Soni PN. Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study). Am J Cardi PubMed
- FDA announces qualified health claims for omega-3 fatty acids. Available at: https://www.fda.gov/Food/LabelingNutrition/ucm072756.htm. Accessed April 15 2019.
- Breastfeeding and the use of human milk. Section on Breastfeeding. Pediatrics. 2012;129(3):e827-41. PubMed
- Zhang Z, Fulgoni VL, Kris-Etherton PM, Mitmesser SH. Dietary Intakes of EPA and DHA Omega-3 Fatty Acids among US Childbearing-Age and Pregnant Women: An Analysis of NHANES 2001-2014. Nutrients. 2018;10(4). PubMed
- Montgomery P, Spreckelsen TF, Burton A, Burton JR, Richardson AJ. Docosahexaenoic acid for reading, working memory and behavior in UK children aged 7-9: A randomized controlled trial for replication (the DOLAB II study). PLoS One. 2018;13(2):e0192909. PubMed
- Rao A, Briskey D, Nalley JO, Ganuza E. Omega-3 eicosapentaenoic acid (EPA) rich extract from the microalga Nannochloropsis decreases cholesterol in healthy individuals: A double-blind, randomized, placebo-controlled, three-month supplementation study. Nut PubMed
- Marc I, Piedboeuf B, Lacaze-Masmonteil T, et al. Effect of maternal docosahexaenoic acid supplementation on bronchopulmonary dysplasia-free survival in breastfed preterm infants: A randomized clinical trial. JAMA. 2020;324(2):157-167. PubMed
- Fougère H, Bilodeau JF, Lavoie PM, et al. Docosahexaenoic acid-rich algae oil supplementation on breast milk fatty acid profile of mothers who delivered prematurely: a randomized clinical trial. Sci Rep 2021;11(1):21492. PubMed
- Yang Y, Li G, Li F, et al. Impact of DHA from algal oil on the breast milk DHA levels of lactating women: A randomized controlled trial in China. Nutrients 2022;14(16):3410. PubMed
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC